Tag: Tryp Therapeutics - Page 5 - Psychedelic Alpha

Read more about the article Tryp Therapeutics Invited to Present at Global Healthcare & Psychedelic Conferences

Tryp Therapeutics Invited to Present at Global Healthcare & Psychedelic Conferences

Post published:January 13, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Appoints Dr. William K. Schmidt to Its Scientific Advisory Board

Tryp Therapeutics Appoints Dr. William K. Schmidt to Its Scientific Advisory Board

Post published:January 7, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Appoints Peter Guzzo, PhD, as Vice President, Drug Development

Tryp Therapeutics Appoints Peter Guzzo, PhD, as Vice President, Drug Development

Post published:December 22, 2020
Post category:Press Release

Read more about the article Tryp Therapeutics Begins Trading on the Canadian Securities Exchange

Tryp Therapeutics Begins Trading on the Canadian Securities Exchange

Post published:December 18, 2020
Post category:Press Release

Read more about the article Tryp Therapeutics Completes Initial Public Offering

Tryp Therapeutics Completes Initial Public Offering

Post published:December 17, 2020
Post category:Press Release

Read more about the article Tryp Therapeutics Announces Full Exercise of Over-Allotment Option on Initial Public Offering

Tryp Therapeutics Announces Full Exercise of Over-Allotment Option on Initial Public Offering

Post published:December 14, 2020
Post category:Press Release

Read more about the article Tryp Therapeutics Files Final Prospectus and Announces Initial Public Offering

Tryp Therapeutics Files Final Prospectus and Announces Initial Public Offering

Post published:December 10, 2020
Post category:Press Release

Read more about the article Tryp Appoints Dr. Jim Gilligan, PhD, MBIS, as President and Chief Scientific Officer

Tryp Appoints Dr. Jim Gilligan, PhD, MBIS, as President and Chief Scientific Officer

Post published:November 12, 2020
Post category:Press Release

Read more about the article Tryp Therapeutics Announces Formation of Psilocybin Scientific Advisory Board

Tryp Therapeutics Announces Formation of Psilocybin Scientific Advisory Board

Post published:October 6, 2020
Post category:Press Release

Read more about the article Tryp Therapeutics Partners with Albany Molecular Research Inc. to Manufacture a Proprietary Psilocybin-based Drug

Tryp Therapeutics Partners with Albany Molecular Research Inc. to Manufacture a Proprietary Psilocybin-based Drug

Post published:August 13, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.